论文部分内容阅读
目的:观察醒脑静注射液治疗脑卒中后昏迷的疗效及安全性。方法:回顾性分析58例卒中后昏迷患者的临床资料。结果:治疗组治疗后格拉斯哥昏迷量表评分明显升高,且较对照组升高明显。治疗组总有效率为78.33%,明显高于对照组的58.93%(P<0.05)。结论:醒脑静注射液治疗脑卒中后昏迷的效果优于常规治疗方法,是治疗脑卒中后昏迷的有效药物。
Objective: To observe the effect and safety of xingnaojing injection in treating post-stroke coma. Methods: A retrospective analysis of 58 patients with post-stroke coma clinical data. Results: After treatment, Glasgow coma scale scores in treatment group were significantly higher than those in control group. The total effective rate in the treatment group was 78.33%, which was significantly higher than that in the control group (58.93%, P <0.05). Conclusion: Xingnaojing Injection is superior to conventional treatment in treating post-stroke coma, and it is an effective drug for treating coma after stroke.